- Home
- CDXS vs FMAO Comparison
CDXS vs FMAO Comparison
Compare CDXS & FMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- FMAO
- Stock Information
- Founded
- CDXS 2002
- FMAO 1897
- Country
- CDXS United States
- FMAO United States
- Employees
- CDXS N/A
- FMAO N/A
- Industry
- CDXS Major Chemicals
- FMAO Savings Institutions
- Sector
- CDXS Industrials
- FMAO Finance
- Exchange
- CDXS Nasdaq
- FMAO Nasdaq
- Market Cap
- CDXS 201.3M
- FMAO 369.3M
- IPO Year
- CDXS 2010
- FMAO N/A
- Fundamental
- Price
- CDXS $3.09
- FMAO $25.99
- Analyst Decision
- CDXS Buy
- FMAO Hold
- Analyst Count
- CDXS 2
- FMAO 1
- Target Price
- CDXS $11.00
- FMAO $26.00
- AVG Volume (30 Days)
- CDXS 939.2K
- FMAO 25.2K
- Earning Date
- CDXS 08-07-2025
- FMAO 07-31-2025
- Dividend Yield
- CDXS N/A
- FMAO 3.43%
- EPS Growth
- CDXS N/A
- FMAO 26.69
- EPS
- CDXS N/A
- FMAO 2.01
- Revenue
- CDXS $49,815,000.00
- FMAO $104,144,000.00
- Revenue This Year
- CDXS $12.77
- FMAO N/A
- Revenue Next Year
- CDXS $22.12
- FMAO $6.16
- P/E Ratio
- CDXS N/A
- FMAO $12.82
- Revenue Growth
- CDXS N/A
- FMAO 9.24
- 52 Week Low
- CDXS $1.90
- FMAO $20.88
- 52 Week High
- CDXS $6.08
- FMAO $34.15
- Technical
- Relative Strength Index (RSI)
- CDXS 69.54
- FMAO 55.43
- Support Level
- CDXS $2.55
- FMAO $26.18
- Resistance Level
- CDXS $2.91
- FMAO $28.24
- Average True Range (ATR)
- CDXS 0.20
- FMAO 1.05
- MACD
- CDXS 0.06
- FMAO 0.13
- Stochastic Oscillator
- CDXS 96.17
- FMAO 53.91
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.